Surface biofunctionalization by covalent co-immobilization of oligopeptides

Colloids and Surfaces B: Biointerfaces

Volumn 107, Issue , 2013, Pages 189-197

  Chen, Xi ^a   Sevilla, Pablo ^b,c   Aparicio, Conrado ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^c Paseo Sant Joan Bosco   (Spain)

Author keywords

Bioactive surface; Biofunctionalization; Co immobilization; Oligopeptide; PHSRN; RGD

Indexed keywords

BIOACTIVE SURFACES; BIOFUNCTIONALIZATION; COIMMOBILIZATION; OLIGOPEPTIDES; PHSRN; RGD;

BIOACTIVITY; COATINGS; FLUORESCENCE;

PEPTIDES;

(3 CHLOROPROPYL)TRIETHOXYSILANE; ARGINYLGLYCYLASPARTIC ACID; FLUORESCENT DYE; MINERAL; OLIGOPEPTIDE; PROPYLHISTIDINYLSERYLARGINYLASPARAGINE; SILANE DERIVATIVE; TITANIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; COVALENT BOND; FLUORESCENCE; IMMOBILIZATION; IMPLANT; IN VITRO STUDY; MATERIAL COATING; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RELIABILITY; SURFACE BIOFUNCTIONALIZATION; SURFACE PROPERTY;

AMINO ACID SEQUENCE; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; IMMOBILIZED PROTEINS; MICE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; OSTEOBLASTS; PHOTOELECTRON SPECTROSCOPY; TITANIUM; ULTRASONICS; WETTABILITY;

EID: 84875066472     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.02.005     Document Type: Article

References (48)

1. Pohler O.E. Unalloyed titanium for implants in bone surgery. Injury 2000, 31(Suppl. 4):7-13.
2. Puleo D.A., Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999, 20:2311-2321.
3. Campoccia D., Montanaro L., Arciola C.R. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006, 27:2331-2339.
4. Bumgardner J.D., Adatrow P., Haggard W.O., Norowski P.A. Emerging antibacterial biomaterial strategies for the prevention of pen-implant inflammatory diseases. Int. J. Oral Max. Implant. 2011, 26:553-560.
5. Beutner R., Michael J., Schwenzer B., Scharnweber D. Biological nano-functionalization of titanium-based biomaterial surfaces: a flexible toolbox. J R Soc Interface 2010, 7:S93-S105.
6. Schliephake H., Scharnweber D. Chemical and biological functionalization of titanium for dental implants. J. Mater. Chem. 2008, 18:2404-2414.
7. Schmidmaier G., Wildemann B., Cromme F., Kandziora F., Haas N.P., Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone 2002, 30:816-822.
8. Xiang W., Baolin L., Yan J., Yang X. The effect of bone morphogenetic protein on osseointegration of titanium implants. J. Oral Maxil. Surg. 1993, 51:647-651.
9. Kim S.E., Song S.H., Yun Y.P., Choi B.J., Kwon I.K., Bae M.S., Moon H.J., Kwon Y.D. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials 2011, 32:366-373.
10. Sverzut A.T., Crippa G.E., Morra M., de Oliveira P.T., Beloti M.M., Rosa A.L. Effects of type I collagen coating on titanium osseointegration: histomorphometric, cellular and molecular analyses. Biomed. Mater. 2012, 7.
11. Beutner R., Michael J., Forster A., Schwenzer B., Scharnweber D. Immobilization of oligonucleotides on titanium based materials by partial incorporation in anodic oxide layers. Biomaterials 2009, 30:2774-2781.
12. Michael J., Beutner R., Hempel U., Scharnweber D., Worch H., Schwenzer B. Surface modification of titanium-based alloys with bioactive molecules using electrochemically fixed nucleic acids. J. Biomed. Mater. Res. B 2007, 80B:146-155.
13. Rammelt S., Illert T., Bierbaum S., Scharnweber D., Zwipp H., Schneiders W. Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate. Biomaterials 2006, 27:5561-5571.
14. Kroese-Deutman H.C., van den Dolder J., Spauwen P.H., Jansen J.A. Influence of RGD-loaded titanium implants on bone formation in vivo. Tissue Eng. 2005, 11:1867-1875.
15. Seo H.S., Ko Y.M., Shim J.W., Lim Y.K., Kook J.K., Cho D.L., Kim B.H. Characterization of bioactive RGD peptide immobilized onto poly(acrylic acid) thin films by plasma polymerization. Appl. Surf. Sci. 2010, 257:596-602.
16. Xiao S.J., Textor M., Spencer N.D., Wieland M., Keller B., Sigrist H. Immobilization of the cell-adhesive peptide Arg-Gly-Asp-Cys (RGDC) on titanium surfaces by covalent chemical attachment. J. Mater. Sci. Mater. M 1997, 8:867-872.
17. Petrie T.A., Raynor J.E., Dumbauld D.W., Lee T.T., Jagtap S., Templeman K.L., Collard D.M., Garcia A.J. Multivalent integrin-specific ligands enhance tissue healing and biomaterial integration. Sci. Transl. Med. 2010, 2.
18. Zhao L.Z., Chu P.K., Zhang Y.M., Wu Z.F. Antibacterial coatings on titanium implants. J. Biomed. Mater. Res. B 2009, 91B:470-480.
19. Lucke M., Schmidmaier G., Sadoni S., Wildemann B., Schiller R., Haas N.P., Raschke M. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 2003, 32:521-531.
20. Alt V., Bitschnau A., Osterling J., Sewing A., Meyer C., Kraus R., Meissner S.A., Wenisch S., Domann E., Schnettler R. The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 2006, 27:4627-4634.
21. Radin S., Campbell J.T., Ducheyne P., Cuckler J.M. Calcium phosphate ceramic coatings as carriers of vancomycin. Biomaterials 1997, 18:777-782.
22. Harris L.G., Tosatti S., Wieland M., Textor M., Richards R.G. Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionalized and peptide-functionalized poly(l-lysine)-grafted-poly(ethylene glycol) copolymers. Biomaterials 2004, 25:4135-4148.
23. Chen X., Li Y., Aparicio C. Biofunctional coatings for dental implants. Thin Films and Coatings in Biology. Biological and Medical Physics-Biomedical Engineering Series 2013, Springer-Verlag, ISBN 978-94-007-2591-1. S. Nazarpour, M. Chaker (Eds.).
24. Chua P.H., Neoh K.G., Kang E.T., Wang W. Surface functionalization of titanium with hyaluronic acid/chitosan polyelectrolyte multilayers and RGD for promoting osteoblast functions and inhibiting bacterial adhesion. Biomaterials 2008, 29:1412-1421.
25. Lee D.W., Yun Y.P., Park K., Kim S.E. Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinized-titanium implant with enhanced antibacterial activity and osteointegration. Bone 2012, 50:974-982.
26. Nanci A., Wuest J.D., Peru L., Brunet P., Sharma V., Zalzal S., McKee M.D. Chemical modification of titanium surfaces for covalent attachment of biological molecules. J. Biomed. Mater. Res. 1998, 40:324-335.
27. Mani G., Johnson D.M., Marton D., Dougherty V.L., Feldman M.D., Patel D., Ayon A.A., Agrawal C.M. Stability of self-assembled monolayers on titanium and gold. Langmuir 2008, 24:6774-6784.
28. Auernheimer J., Zukowski D., Dahmen C., Kantlehner M., Enderle A., Goodman S.L., Kessler H. Titanium implant materials with improved riocompatibility through coating with phosphonate-anchored cyclic RGD peptides. Chembiochem 2005, 6:2034-2040.
29. Tan G.X., Zhang L., Ning C.Y., Liu X.J., Liao J.W. Preparation and characterization of APTES films on modification titanium by SAMs. Thin Solid Films 2011, 519:4997-5001.
30. Lloyd-Williams P., Albericio F., Giralt E. Chemical Approaches to the Synthesis of Peptides and Proteins (New Directions in Organic & Biological Chemistry) 1997, CRC-Press, Boca Raton London Washington, DC.
31. Pierschbacher M.D., Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984, 309:30-33.
32. Ochsenhirt S.E., Kokkoli E., McCarthy J.B., Tirrell M. Effect of RGD secondary structure and the synergy site PHSRN on cell adhesion, spreading and specific integrin engagement. Biomaterials 2006, 27:3863-3874.
33. Benoit D.S.W, Anseth K.S. The effect on osteoblast function of colocalized RGD and PHSRN epitopes on PEG surfaces. Biomaterials 2005, 26:5209-5220.
34. Kao W.J., Lee D., Schense J.C., Hubbell T.A. Fibronectin modulates macrophage adhesion and FBGC formation: the pole of RGD, PHSRN, and PRRARV domains. J. Biomed. Mater. Res. 2001, 55:79-88.
35. Feng Y.Z., Mrksich M. The synergy peptide PHSRN and the adhesion peptide RGD mediate cell adhesion through a common mechanism. Biochemistry-US 2004, 43:15811-15821.
36. Schmidt D.R., Kao W.J. Monocyte activation in response to polyethylene glycol hydrogels grafted with RGD and PHSRN separated by interpositional spacers of various lengths. J. Biomed. Mater. Res. A 2007, 83A:617-625.
37. Petrie T.A., Capadona J.R., Reyes C.D., Garcia A.J. Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports. Biomaterials 2006, 27:5459-5470.
38. Benoit D.S., Anseth K.S. The effect on osteoblast function of colocalized RGD and PHSRN epitopes on PEG surfaces. Biomaterials 2005, 26:5209-5220.
39. Kokkoli E., Ochsenhirt S.E., Tirrell M. Collective and single-molecule interactions of alpha(5)beta(1) integrins. Langmuir 2004, 20:2397-2404.
40. Mardilovich A., Kokkoli E. Biomimetic peptide-amphiphiles for functional biomaterials: the role of GRGDSP and PHSRN. Biomacromolecules 2004, 5:950-957.
41. Hopp T.P., Woods K.R. Prediction of protein antigenic determinants from amino-acid-sequences. Proc Natl Acad Sci-Biol 1981, 78:3824-3828.
42. Shi Z.L., Neoh K.G., Kang E.T., Poh C., Wang W. Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions. Tissue Eng. Part A 2009, 15:417-426.
43. Zhang F., Zhang Z.B., Zhu X.L., Kang E.T., Neoh K.G. Silk-functionalized titanium surfaces for enhancing osteoblast functions and reducing bacterial adhesion. Biomaterials 2008, 29:4751-4759.
44. Zhang F., Shi Z.L., Chua P.H., Kang E.T., Neoh K.G. Functionalization of titanium surfaces via controlled living radical polymerization: from antibacterial surface to surface for osteoblast adhesion. Ind. Eng. Chem. Res. 2007, 46:9077-9086.
45. Xiao S.J., Textor M., Spencer N.D., Sigrist H. Covalent attachment of cell-adhesive, (Arg-Gly-Asp)-containing peptides to titanium surfaces. Langmuir 1998, 14:5507-5516.
46. Busscher H.J., van der Mei H.C., Subbiahdoss G., Jutte P.C., van den Dungen J.J.A.M., Zaat S.A.J., Schultz M.J., Grainger D.W. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci. Transl. Med. 2012, 4.
47. Fowler T., Wann E.R., Joh D., Johansson S.A., Foster T.J., Hook M. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta 1 integrins. Eur. J. Cell Biol. 2000, 79:672-679.
48. Subbiahdoss G., Pidhatika B., Coullerez G., Charnley M., Kuijer R., van der Mei H.C., Textor M., Busscher H.J. Bacterial biofilm formation versus mammalian cell growth on titanium-based mono- and bi-functional coating. Eur. Cell Mater. 2010, 19:205-213.